December 21 (SeeNews) - Bulgarian drug distributor Sopharma Trading [BUL:SO5] said on Wednesday its pre-tax profit rose to 14 million levs ($7.5 million/7.1 million euro) in the period January-November, from 13.7 million levs in the corresponding period of last year.
Sales revenue in the first eleven months increased to 557.3 million levs, from 552.3 million levs last year, the company said in a bourse filing.
In November alone, Sopharma Trading’s pre-tax profit rose 6% year-on-year, reaching 1.4 million levs, as sales revenue increased 9% to 55.1 million levs.
Sopharma Trading is a unit of Bulgarian drug maker Sopharma [BUL:3JR].
(1 euro=1.95583 levs)